Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry
Authors: Sedaghat Alexander , Vij Vivian , Al-Kassou Baravan , Gloekler Steffen , Galea Roberto , Fürholz Monika , Meier Bernhard , Valgimigli Marco , O’Hara Gilles , Arzamendi Dabit , Agudelo Victor , Asmarats Lluis , Freixa Xavier , Flores-Umanzor Eduardo , De Backer Ole , Søndergaard Lars , Nombela-Franco Luis , McInerney Angela , Korsholm Kaspar , Nielsen-Kudsk Jens Erik , Afzal Shazia , Zeus Tobias , Operhalski Felix , Schmidt Boris , Montalescot Gilles , Guedeney Paul , Iriart Xavier , Miton Noelie , Saw Jacqueline , Gilhofer Thomas , Fauchier Laurent , Veliqi Egzon , Meincke Felix , Petri Nils , Nordbeck Peter , Rycerz Szymon , Ognerubov Dmitrii , Merkulov Evgeny , Cruz-González Ignacio , Gonzalez-Ferreiro Rocio , Bhatt Deepak L. , Laricchia Alessandra , Mangieri Antonio , Omran Heyder , Schrickel Jan Wilko , Rodes-Cabau Josep , Nickenig Georg 
Published: May 2021

Background:

Left atrial appendage closure is an established therapy in patients with atrial fibrillation. Although device-related thrombosis (DRT) is relatively rare, it is potentially linked to adverse events. As data on DRT characteristics, outcome, and treatment regimen are scarce, we aimed to assess these questions in a multicenter approach.

Methods:

One hundred fifty-six patients with the diagnosis of DRT after left atrial appendage closure were included in the multinational EUROC-DRT registry. Baseline characteristics included clinical and echocardiographic data. After inclusion, all patients underwent further clinical and echocardiographic follow-up to assess DRT dynamics, treatment success, and outcome.

Results:

DRT was detected after a median of 93 days (interquartile range, 54–161 days) with 17.9% being detected >6 months after left atrial appendage closure. Patients with DRT were at high ischemic and bleeding risk (CHA
2
DS
2
-VASc 4.5±1.7, HAS-BLED 3.3±1.2) and had nonparoxysmal atrial fibrillation (67.3%), previous stroke (53.8%), and spontaneous echo contrast (50.6%). The initial treatment regimens showed comparable resolution rates (antiplatelet monotherapy: 57.1%, dual antiplatelet therapy: 85.7%, vitamin K antagonists: 80.0%, novel oral anticoagulants: 75.0%, and heparin: 68.6%). After intensification or switch of treatment, complete DRT resolution was achieved in 79.5% of patients. Two-year follow-up revealed a high risk of mortality (20.0%) and ischemic stroke (13.8%) in patients with DRT. Patients with incomplete DRT resolution showed numerically higher stroke rates and increased mortality rates (stroke: 17.6% versus 12.3%,
P
=0.29; mortality: 31.3% versus 13.1%,
P
=0.05).

Conclusions:

A substantial proportion of DRT is detected >6 months after left atrial appendage closure, highlighting the need for imaging follow-up. Patients with DRT appear to be at a high risk for stroke and mortality. While DRT resolution was achieved in most patients, incomplete DRT resolution appeared to identify patients at even higher risk. Optimal DRT diagnostic criteria and treatment regimens are warranted.